EP2769737
Samband and-CTLA4 mótefnis með etópósíð samverkandi meðferð á fjölgunarsjúkdómum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.10.2009EP published:
5.4.2017EP application number:
14162613.5
EP translation filed:
10.5.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
28.10.2029Expiry date:
28.10.2026Next due date:
31.10.2026
Title:
Combination of an anti-CTLA4 antibody with etoposide for the synergistic treatment of proliferative diseases
Timeline
Today
29.10.2009EP application
5.4.2017EP Publication
10.5.2017Translation submitted
15.6.2017Registration published
28.10.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, 08543, Princeton, NJ, US
Inventor
Name:
Lee, Francis, Y.Address:
Princeton, NJ New Jersey, US
Name:
Jure-Kunkel, MariaAddress:
Princeton, NJ New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
226910 PDate:
20.7.2009Country:
US
Number:
462168Date:
30.7.2009Country:
US
Number:
PCT/US2009/052209Date:
30.7.2009Country:
WO
Classification
Categories:
A61K 45/06, A61K 39/395, A61K 31/385, A61K 31/506, A61K 31/337, C07K 16/28, A61K 33/24, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 11.9.2017
Expires: 28.10.2018
Payer: Árnason Faktor
Number: 10
Paid: 6.9.2018
Expires: 28.10.2019
Payer: Árnason Faktor
Number: 11
Paid: 9.9.2019
Expires: 28.10.2020
Payer: Árnason Faktor
Number: 12
Paid: 9.9.2020
Expires: 28.10.2021
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.9.2021
Expires: 28.10.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 7.9.2022
Expires: 28.10.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 13.10.2023
Expires: 28.10.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 17.9.2024
Expires: 28.10.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 10.10.2025
Expires: 28.10.2026
Payer: Árnason Faktor ehf.